国家: 爱尔兰
语言: 英文
来源: HPRA (Health Products Regulatory Authority)
RISEDRONATE SODIUM
Pharmathen S.A.
M05BA07
RISEDRONATE SODIUM
30 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
Bisphosphonates
Authorised
2010-11-26
PACKAGE LEAFLET: INFORMATION FOR THE USER BONAPENYA 30 MG FILM-COATED TABLETS Risedronate sodium READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects talk to your doctor or pharmacist or nurse.This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Bonapenya is and what it is used for 2. What you need to know before you take Bonapenya 3. How to take Bonapenya 4. Possible side effects 5. How to store Bonapenya 6. Contents of the pack and other information 1. WHAT BONAPENYA IS AND WHAT IT IS USED FOR WHAT BONAPENYA IS Bonapenya belongs to a group of non-hormonal medicines called bisphosphonates which are used to treat bone diseases. It works directly on your bones to make them stronger and therefore less likely to break. Bone is a living tissue. Old bone is constantly removed from your skeleton and replaced with new bone. Paget’s disease occurs when this process, called remodeling, happens too quickly and in a disordered way. The new bone that is produced is weaker than normal and the affected bones may become enlarged, painful and may fracture. Bonapenya changes the bone remodeling process back to normal, returning the strength to the bone structure. WHAT BONAPENYA IS USED FOR Treatment of Paget´s disease of the bone (osteitis deformans). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE BONAPENYA DO NOT TAKE BONAPENYA - if you are ALLERGIC to risedronate sodium or any of the other ingredients of this medicine (listed in section 6) . - if your doctor has told you that you have a condition called HYPOCALCAEMIA (a lo 阅读完整的文件
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Bonapenya 30mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 30 mg risedronate sodium (equivalent to 27.8 mg risedronic acid). Excipient: 1.9 mg lactose in each tablet. For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. White round biconvex film-coated tablet with diameter of 11.2 mm, 4.5 mm in thickness and embossed with “30” on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of Paget’s disease of the bone. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY The recommended daily dose in adults is one 30 mg tablet orally for 2 months. If re-treatment is considered necessary (at least two months post-treatment), a new treatment with the same dose and duration of therapy could be given. METHOD OF ADMINISTRATION The absorption of Risedronate is affected by food, thus to ensure adequate absorption patients should take Risedronate: Before breakfast: At least 30 minutes before the first food, other medicinal product or drink (other than plain water) of the day. In the particular instance that before breakfast dosing is not practical, Risedronate can be taken between meals or in the evening at the same time everyday, with strict adherence to the following instructions, to ensure Risedronate is taken on an empty stomach: Between meals: Risedronate should be taken at least 2 hours before and at least 2 hours after any food, medicinal product or drink (other than plain water). In the evening: Risedronate should be taken at least 2 hours after the last food, medicinal product or drink (other than plain water) of the day. Risedronate should be taken at least 30 minutes before going to bed. If a 阅读完整的文件